Public Health vs. Multinational Profits: Building a Policy Shield Against New Tobacco Traps

The departmental store located barely eighty meters from a well-known English-medium school in the capital appears sleek and modern at first glance.

Yet, a closer look at its glass showcase reveals a troubling contradiction. Neatly arrayed inside are colorful vaping devices and e-cigarettes in enticing flavors like mango, lychee, strawberry, and chocolate. Placed right beside them are cigarettes in stylish packaging labeled as “light” or “smooth.”

During tiffin breaks and after school hours, teenagers gather around the counter, buying these items out of curiosity and sharing them with friends. While this might look like a routine commercial scene, it is actually the outcome of a calculated and far-reaching economic strategy by multinational tobacco companies.

The tobacco business is unlike any other commercial enterprise; its economic logic is fundamentally predatory. As older smokers quit or pass away due to age and chronic health conditions, tobacco corporations require a continuous stream of new “nicotine consumers” or “replacement smokers” to sustain their profits.

To fill this void, these companies have targeted adolescents and young adults. By leveraging sleek gadgetry, sweet aromas, and deceptive propaganda that frames e-cigarettes as “less harmful” or a “symbol of sophistication,” they penetrate the psychological domain of impressionable minds.

Medical science, however, confirms that the chemical liquid and nicotine in e-cigarettes accelerate addiction, impair developing adolescent brains, and cause severe pulmonary diseases.

To counter this aggressive corporate expansion, Article 5.3 of the World Health Organization’s (WHO) Framework Convention on Tobacco Control (FCTC) serves as a vital policy instrument.

The core principle of Article 5.3 mandates that ratifying nations must protect their public health policies from the commercial and vested interests of the tobacco industry. Public health goals and tobacco industry profits are inherently irreconcilable.

A state seeks to safeguard its citizens, reduce addiction, and prevent premature deaths, whereas a tobacco company seeks to expand its consumer base to maximize dividends.

Because of this fundamental conflict of interest, international law explicitly bars governments from treating tobacco companies as legitimate “stakeholders” in health policy formulation.

In Bangladesh, however, the reality remains starkly different. The country consistently scores poorly on the Global Tobacco Industry Interference Index.

Whenever the government initiates amendments to the Smoking and Tobacco Products Usage (Control) Act-aimed at banning e-cigarettes, prohibiting single-stick cigarette sales, or eliminating “designated smoking areas” in public places-multinational corporations launch intense lobbying campaigns.

They issue alarmist letters to the Ministries of Finance, Commerce, and Industries, warning of catastrophic revenue drops and the collapse of small retail livelihoods.

Simultaneously, under the guise of Corporate Social Responsibility (CSR) programs-such as tree plantation drives, clean water projects, or youth startup competitions-they attempt to polish their public image and portray themselves as development partners.

Proponents of the industry often argue that tobacco corporations contribute substantial tax revenue to the public exchequer and that all legal businesses deserve the right to trade in a free market. While this argument may sound appealing on the surface, rigorous analysis exposes its flaws.

The revenue collected from the tobacco sector is far outweighed by the economic burden imposed on the country due to healthcare costs and lost productivity. Research by the Bangladesh Cancer Society and the University of Dhaka reveals that tobacco use costs the Bangladeshi economy over BDT 30,000 crore annually-equivalent to roughly 1.4 percent of the national GDP.

Furthermore, data from the Global Burden of Disease study indicates that tobacco-related illnesses claim more than 199,000 lives in Bangladesh every year. Relying on revenue that comes at the expense of massive mortality and crippling health expenditures is a false economy.

Although Bangladesh was among the first countries to sign the FCTC, it has yet to enact a binding, unified national policy directive incorporating Article 5.3. A major structural conflict of interest persists: the government retains an equity stake in British American Tobacco Bangladesh (BATB), and senior civil servants sit on its board of directors.

Consequently, whenever the Ministry of Health proposes stricter regulations or higher ad-valorem taxes, government officials serving on the company’s board frequently align with commercial interests, citing revenue concerns. This state of affairs represents a direct breach of FCTC Article 5.3 guidelines.

Several nations have successfully neutralized such corporate tactics. Countries like Australia, New Zealand, and Thailand require full public disclosure of all interactions between government officials and tobacco representatives, while completely banning corporate CSR activities and indirect marketing. India has similarly issued mandatory guidelines for all government departments to enforce Article 5.3 and prevent industry interference.

It is time for Bangladesh to resolve its policy ambiguity. Protecting the younger generation from nicotine’s evolving guises requires decisive and structured intervention.

First, the draft national guidelines on FCTC Article 5.3 prepared by the Ministry of Health must receive cabinet approval and be made legally binding across all government ministries and public offices.

Second, government officials must be withdrawn from the board of directors of tobacco companies, and a clear divestment strategy for state-owned shares must be initiated. Third, Parliament must swiftly pass the proposed tobacco control amendments-banning e-cigarettes, halting single-stick sales, prohibiting sales within 100 meters of educational institutions, and outlawing corporate CSR initiatives.

Public health is a constitutional right, not a negotiable commodity. The long-term health, productivity, and wellbeing of millions of young citizens far outweigh the temporary financial returns of multinational corporations.

Policymakers must realize that capitulating to corporate lobbying compromises the country’s demographic dividend and exposes the youth to a preventable epidemic of non-communicable diseases. Enforcing FCTC Article 5.3 is no longer merely a regulatory recommendation; it is an imperative for the nation’s future.

(The writer is a Public Health and Environment Activist)